Veracyte, Inc.
NasdaqGM:VCYT
Sector
Location
Market Cap
USD 2.17 B
Share Price
USD 27.37
Avg Daily Volume
1,395,948
Change (1 day)
-1.12%
Change (1 year)
-8.67%
Change (YTD)
-30.88%
Veracyte, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2025: 12.26%
Veracyte, Inc. EBITDA Margin is 12.26% for the Trailing 12 Months (TTM) ending June 30, 2025, a -254.29% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
Veracyte, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was -7.95%, a 5,729.84% change year over year.
-
Veracyte, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was -0.14%, a -98.38% change year over year.
-
Veracyte, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was -8.42%, a -75.72% change year over year.
-
Veracyte, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was -34.67%, a 59.11% change year over year.
StockViz
Competitors
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
Thermo Fisher Scientific Inc.
USD 460.72
TMO
+5.98
1.31%
Boston Scientific Corporation
USD 103.14
BSX
+0.18
0.18%
Becton, Dickinson and Company
USD 193.50
BDX
+5.82
3.10%
Fresenius SE & Co. KGaA
USD 50.92
FRE.DE
+1.60
3.26%
Sartorius Stedim Biotech S.A.
USD 194.24
DIM.PA
-1.25
-0.64%
bioMérieux S.A.
USD 145.17
BIM.PA
-0.75
-0.51%
United Therapeutics Corporation
USD 301.50
UTHR
+2.08
0.69%
Medpace Holdings, Inc.
USD 434.35
MEDP
+5.56
1.30%
Revvity, Inc.
USD 86.84
RVTY
+0.38
0.44%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.84
603392.SS
-0.02
-0.30%
Exact Sciences Corporation
USD 40.99
EXAS
-2.17
-5.03%
Sysmex Corporation
USD 13.84
6869.T
-0.03
-0.23%
Bio-Techne Corporation
USD 50.42
TECH
+0.27
0.54%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.65
002294.SZ
-0.03
-0.39%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|
Competitors
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
Thermo Fisher Scientific Inc.
USD 460.72
TMO
+5.98
1.31%
Boston Scientific Corporation
USD 103.14
BSX
+0.18
0.18%
Becton, Dickinson and Company
USD 193.50
BDX
+5.82
3.10%
Fresenius SE & Co. KGaA
USD 50.92
FRE.DE
+1.60
3.26%
Sartorius Stedim Biotech S.A.
USD 194.24
DIM.PA
-1.25
-0.64%
bioMérieux S.A.
USD 145.17
BIM.PA
-0.75
-0.51%
United Therapeutics Corporation
USD 301.50
UTHR
+2.08
0.69%
Medpace Holdings, Inc.
USD 434.35
MEDP
+5.56
1.30%
Revvity, Inc.
USD 86.84
RVTY
+0.38
0.44%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.84
603392.SS
-0.02
-0.30%
Exact Sciences Corporation
USD 40.99
EXAS
-2.17
-5.03%
Sysmex Corporation
USD 13.84
6869.T
-0.03
-0.23%
Bio-Techne Corporation
USD 50.42
TECH
+0.27
0.54%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.65
002294.SZ
-0.03
-0.39%